Inotuzumab ozogamicin


CAS No. : 635715-01-4

(Synonyms: CMC-544; PF-5208773; WAY-207294)

635715-01-4
Price and Availability of CAS No. : 635715-01-4
Size Price Stock
100μg $3000 Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-P9959
M.Wt: 1000.00
Formula: N/A
Purity: >98 %
Solubility: H2O
Introduction of 635715-01-4 :

Inotuzumab ozogamicin (CMC-544) is an antibody-targeted chemotherapy agent composed of a humanized anti-CD22 antibody conjugated to Calicheamicin (HY-19609). Inotuzumab ozogamicin and G544 bind human CD22 with similar affinities (Kd ≈ 150 pM). Inotuzumab ozogamicin has demonstrated efficacy against CD22+ B-cell non-Hodgkin’s lymphoma. Inotuzumab ozogamicin can be used in the research of acute lymphoblastic leukemia[1][2][3]. IC50 & Target:Kd ≈ 150 pM (CD22)[1] In Vitro:Inotuzumab ozogamicin exerts highly potent cytotoxic activity against a vari-
ety of CD22-positive B-cell origin cancer cell lines[1].
Inotuzumab ozogamicin and G544
bind human CD22 with similar affinities (KD ≈ 150 pM)[1]. In Vivo:Inotuzumab ozogamicin causes dose-dependent regression of B-lymphoma xenografts grown as subcutaneous solid tumors in athymic nude mice[1].

Your information is safe with us.